"Advanced renal cancer" trang 1 - tải miễn phí từ tailieunhanh
Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus

Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus
8    81    1
Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer

Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer
7    53    1
Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: A case report

Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: A case report
10    54    1
PRISM protocol: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in firstline treatment of patients with advanced or metastatic renal cell carcinoma

PRISM protocol: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in firstline treatment of patients with advanced or metastatic renal cell carcinoma
9    85    0
Phase II study of carboplatin/nab-paclitaxel/ atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial

Phase II study of carboplatin/nab-paclitaxel/ atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial
5    1    1
Efficacy and safety analysis of TACE+sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: A retrospective study

Efficacy and safety analysis of TACE+sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: A retrospective study
11    5    1
Budget impact analysis of first-line treatment with pazopanib for advanced renal cell carcinoma in Spain

Budget impact analysis of first-line treatment with pazopanib for advanced renal cell carcinoma in Spain
9    71    1
Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients

Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients
11    60    1
A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes

A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes
12    25    1
Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: Pooled subgroup analysis from the randomized, COMPARZ studies

Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: Pooled subgroup analysis from the randomized, COMPARZ studies
8    56    0
Pazopanib has equivalent anti-tumor effectiveness and lower Total costs than Sunitinib for treating metastatic or advanced renal cell carcinoma: A metaanalysis

Pazopanib has equivalent anti-tumor effectiveness and lower Total costs than Sunitinib for treating metastatic or advanced renal cell carcinoma: A metaanalysis
12    62    0
Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors
10    71    1
FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: Max SUVmax predicts survival of patients with advanced renal cell carcinoma

FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: Max SUVmax predicts survival of patients with advanced renal cell carcinoma
7    43    1
ExPert ConsEnsus on the management of Advanced clear-cell RenaL celL carcinoma: INDIAn Perspective (PEARL‑INDIA)

ExPert ConsEnsus on the management of Advanced clear-cell RenaL celL carcinoma: INDIAn Perspective (PEARL‑INDIA)
13    1    1
Advanced sporadic renal epithelioid angiomyolipoma: Case report of an extraordinary response to sirolimus linked to TSC2 mutation

Advanced sporadic renal epithelioid angiomyolipoma: Case report of an extraordinary response to sirolimus linked to TSC2 mutation
5    69    1
Advanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: Report of a case

Advanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: Report of a case
7    42    1
Identification of the potential novel biomarkers as susceptibility gene for Wilms tumor

Identification of the potential novel biomarkers as susceptibility gene for Wilms tumor
15    43    1
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: Results from a phase 1b/2 study

Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: Results from a phase 1b/2 study
14    7    1